These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32306946)

  • 41. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.
    Malacarne P; Rossi C; Bertolini G;
    J Antimicrob Chemother; 2004 Jul; 54(1):221-4. PubMed ID: 15190030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E; Morosini MI; Pascual A; Tubau F; Alcalá J; Liñares J; Hernández-Bello JR; Baquero F; Perea E; Martín R; Jones RN; Cantón R;
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong.
    Ng CK; Wu TC; Chan WM; Leung YS; Li CK; Tsang DN; Leung GM
    Qual Saf Health Care; 2008 Oct; 17(5):387-92. PubMed ID: 18842981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial.
    van Duijn PJ; Verbrugghe W; Jorens PG; Spöhr F; Schedler D; Deja M; Rothbart A; Annane D; Lawrence C; Nguyen Van JC; Misset B; Jereb M; Seme K; Šifrer F; Tomiç V; Estevez F; Carneiro J; Harbarth S; Eijkemans MJC; Bonten M;
    Lancet Infect Dis; 2018 Apr; 18(4):401-409. PubMed ID: 29396000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diversity in antibiotic use in intensive care units in Germany].
    Meyer E; Schwab F; Schroeren-Boersch B; Rüden H; Gastmeier P
    Dtsch Med Wochenschr; 2008 Feb; 133(6):235-40. PubMed ID: 18236348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome.
    Rimawi RH; Mazer MA; Siraj DS; Gooch M; Cook PP
    Crit Care Med; 2013 Sep; 41(9):2099-107. PubMed ID: 23873275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotics in surgical wards: use or misuse? A newly industrialized country's perspective.
    Lim MK; Lai PS; Ponnampalavanar SS; Syed Omar SF; Taib NA; Yusof MY; Italiano CM; Kong DC; Kamarulzaman A
    J Infect Dev Ctries; 2015 Nov; 9(11):1264-71. PubMed ID: 26623636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial.
    López H; Li JZ; Balan DA; Willke RJ; Rittenhouse BE; Mozaffari E; Vidal G; Zitto T; Tang T
    Clin Ther; 2003 Jun; 25(6):1846-71. PubMed ID: 12860502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and analysis of a pharmacist-enhanced antimicrobial stewardship program in Thailand.
    Apisarnthanarak A; Lapcharoen P; Vanichkul P; Srisaeng-Ngoen T; Mundy LM
    Am J Infect Control; 2015 Sep; 43(9):956-9. PubMed ID: 26095656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial stewardship in an Internal Medicine ward: effects on antibiotic consumption and on the use of carbapenems.
    Fortini A; Faraone A; Di Pietro M; Cappugi C; Magnante G; Boccadori C; Bartolini S; Rabatti L
    Intern Emerg Med; 2018 Dec; 13(8):1219-1226. PubMed ID: 30032340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A survey on infection management practices in Italian ICUs.
    Bassetti M; De Gaudio R; Mazzei T; Morace G; Petrosillo N; Viale P; Bello G; La Face S; Antonelli M
    Crit Care; 2012 Nov; 16(6):R221. PubMed ID: 23151325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a Second-Sign Process for Antimicrobial Prior Authorization.
    Dassner AM; Girotto JE
    J Pediatric Infect Dis Soc; 2018 May; 7(2):113-118. PubMed ID: 28407067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of antibiotics for the treatment of multiresistant gram positive cocci infections in critical patients].
    Rodríguez Colomo O; Alvarez Lerma F; Alvarez Sánchez B; Oltra Chordá R; Barcenilla Gaite F; Cereijo Martín-Grande E; Cuñat de la Hoz J; Martínez Pellús A;
    Med Intensiva; 2008; 32(6):263-71. PubMed ID: 18601833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback.
    Wilde AM; Nailor MD; Nicolau DP; Kuti JL
    Pharmacotherapy; 2012 Aug; 32(8):755-63. PubMed ID: 23307523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compliance with the current recommendations for prescribing antibiotics for paediatric community-acquired pneumonia is improving: data from a prospective study in a French network.
    Launay E; Levieux K; Levy C; Dubos F; Martinot A; Vrignaud B; Lepage F; Cohen R; Grimprel E; Hanf M; Angoulvant F; Gras-Le Guen C;
    BMC Pediatr; 2016 Aug; 16(1):126. PubMed ID: 27520057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.